Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $2.98 Million - $4.4 Million
-154,951 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $6,710 - $13,426
335 Added 0.22%
154,951 $3.5 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $1.73 Million - $2.67 Million
-67,047 Reduced 30.25%
154,616 $5.57 Million
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $2.34 Million - $4.16 Million
-106,040 Reduced 32.36%
221,663 $6.99 Million
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $597,953 - $902,491
-30,063 Reduced 8.4%
327,703 $8.24 Million
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $4.92 Million - $11.7 Million
-406,766 Reduced 53.2%
357,766 $10.3 Million
Q2 2018

Aug 14, 2018

BUY
$7.93 - $15.79 $1.62 Million - $3.22 Million
203,932 Added 36.38%
764,532 $9.36 Million
Q1 2018

May 14, 2018

BUY
$5.18 - $7.97 $2.9 Million - $4.47 Million
560,600 New
560,600 $4.47 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.25B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.